Review immune response of targeting CD39 in cancer

Abstract The ATP-adenosine pathway has emerged as a promising target for cancer therapy, but challenges remain in achieving effective tumor control. Early research focused on blocking the adenosine generating enzyme CD73 and the adenosine receptors A2AR or A2BR in cancer. However, recent studies hav...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Yao Liu, Zhongliang Li, Xiaoguang Zhao, Jing Xiao, Jiacheng Bi, Xian-Yang Li, Guokai Chen, Ligong Lu
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2023-06-01
Цуврал:	Biomarker Research
Нөхцлүүд:	CD39 Adenosine pathway Immune checkpoint blockade (ICB) PD-1
Онлайн хандалт:	https://doi.org/10.1186/s40364-023-00500-w
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!